O
Oxana Polyakova
Researcher at GlaxoSmithKline
Publications - 9
Citations - 582
Oxana Polyakova is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Netherton syndrome & LEKTI. The author has an hindex of 5, co-authored 8 publications receiving 446 citations.
Papers
More filters
Journal ArticleDOI
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
Huw D. Lewis,John Liddle,Jim E Coote,Stephen John Atkinson,Michael David Barker,Benjamin D. Bax,Kevin L. Bicker,Ryan P. Bingham,Matthew Campbell,Yu Hua Chen,Chun-wa Chung,Peter D. Craggs,Robert P. Davis,Dirk Eberhard,Gerard Joberty,Kenneth E Lind,Kelly Locke,Claire Maller,Kimberly Martinod,Chris Patten,Oxana Polyakova,Cecil E Rise,Martin Rüdiger,Robert J. Sheppard,Daniel J. Slade,Pamela Thomas,Jim Thorpe,Gang Yao,Gerard Drewes,Denisa D. Wagner,Paul R. Thompson,Rab K. Prinjha,David Matthew Wilson +32 more
TL;DR: Novel, selective PAD4 inhibitors binding to a calcium-deficient form of the PAD3 enzyme have been validated, for the first time, in both histone citrullination and neutrophil extracellular trap formation, validating the critical enzymatic role of human and mouse PAD 4.
Journal ArticleDOI
Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket
John D. Harling,Angela M. Deakin,Sebastien Andre Campos,Rachel Grimley,Laiq Chaudry,Catherine Nye,Oxana Polyakova,Christina M. Bessant,Nick Barton,Don O. Somers,John Barrett,Rebecca H. Graves,Laura Hanns,William J. Kerr,Roberto Solari +14 more
TL;DR: This study confirms the irreversible covalent binding of the inhibitor to the kinase by x-ray crystallography and enzymology while demonstrating potency, selectivity, and prolonged duration of action in in vitro biological assays.
Journal ArticleDOI
Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFκB responses.
Rachel Grimley,Oxana Polyakova,Jessica Vamathevan,Joanne McKenary,Brian Hayes,Champa Patel,Janet L. Smith,Angela Bridges,Andrew P. Fosberry,Anshu Bhardwaja,Bernadette Mouzon,Chun-wa Chung,Nathalie Barrett,Nicola J. Richmond,Sundip Modha,Roberto Solari +15 more
TL;DR: It is confirmed in cellular assays that SIRT6 can deacetylate acetylated-histone H3 lysine 9 (H3K9Ac), however this de acetylase activity is unusually low in biochemical assays.
Journal ArticleDOI
Identification of novel interacting partners of Sirtuin6.
TL;DR: A number of interacting partners are reported which strengthen previous findings that SIRT6 functions in base excision repair (BER), and novel interactors which suggest a role in nucleosome and chromatin remodeling, the cell cycle and NFκB biology.
Journal ArticleDOI
Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.
Gemma Victoria White,Emma V. Edgar,Duncan S. Holmes,Xiao Qing Lewell,John Liddle,Oxana Polyakova,Kathrine J. Smith,James H. Thorpe,Ann Louise Walker,Yichen Wang,Robert J. Young,Alain Hovnanian +11 more
TL;DR: X-ray crystallography was used to find alternatives to the phenol interaction leading to identification of carbonyl analogues such as lactam 13 and benzimidazole 15, which provided novel starting points for the guided growth towards suitable tool molecules for the exploration of KLK5 biology.